Skip to main content

Oncolytics Bio(ONC-T)
TSX

Today's Change
Real-Time Last Update

Current Target Price

High Target Price
Mean Target Price
Low Target Price
Median Target Price

Earnings Estimates

  Current Qtr12/2025Next Qtr03/2026Fiscal Yr12/2025Fiscal Yr12/2026
Average Estimate -0.08 -0.09 -0.36 -0.37
Number of Estimates 1 1 2 2
High Estimate -0.08 -0.09 -0.35 -0.35
Low Estimate -0.08 -0.09 -0.37 -0.39
Prior Year -0.10 -0.08 -0.41 -0.36
Growth Rate Est. (year over year) +20.00% -12.50% +12.20% -2.78%

Earnings History - Surprises*

  Qtr Ending09/2025Qtr Ending06/2025Qtr Ending03/2025Qtr Ending12/2024
Reported $-0.14 $-0.07 $-0.08 $-0.10
Estimate $-0.16 $-0.15 N/A $-0.11
Difference +0.02 +0.08 N/A +0.01
Surprise +12.50% +53.33% N/A +9.09%
* Earnings are based on GAAP income from continuing operations.

Average Analyst Ratings

Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.29
3 Mths Ago7
4.29
2 Mths Ago7
4.29
1 Mth Ago7
4.29
Current7

Ratings Values:

Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1

Ratings Breakdown

 3 Mths Ago2 Mths Ago1 Mth AgoCurrent
# of Analysts:7777
 
3
3
3
3
3
3
3
3
Holds1111
 

Key:

Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell

More from The Globe

How the valuations of TSX utility stocks stack up
Brian Donovan